Dr. Joseph Fraiman
speaker
522 appearances
2 recordings
1 series
first heard Dec 2025
last heard 4 Sep
Dr. Joseph Fraiman’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.
Appearances
These issues really have not really caused a stir because, you know, for each drug that gets approved, generally they are for one small disease and it doesn't affect the whole population.
But for this one, not only did it affect the whole population, it was mandated onto a large percentage of them.
That is false.
No, that is not accurate.
ACIP, the ones who make recommendations for the CDC, no, they are allowed to gather research from a large amount of sources.
Within their conferences, they present information from various different places.
including from from industry but it is not it is not only however generally for the i may are they talking about they might be talking about veer back which is the committee they asked about that also they've been back here back beer back yes generally is is only receiving information from generally i would say is only getting their information from from industry and that's because
The way that our current system works is if you want to get your vaccine or your drug approved, then the company, the industry pays for the trial.
So they have all the access to the information.
No one else is doing a study on their drug.
And then we make a decision on this.
And I believe I said this on the last part of your show, last time I was on your show, and that the absurdity of that is it's crazy because we're listening to the manufacturer's review of their own product, which we wouldn't even do for anything that we bought off of Amazon.
You rarely read what the company tells you when you're buying a product on Amazon.
You look to the independent reviews and how we have not figured out that this is an absurd system, that we don't have an independent party performing studies of evaluating our drugs.
And we're essentially taking whoever the electric toothbrush manufacturers are.
You wouldn't do it for an electric toothbrush, you know, and yet we do it for dangerous, potentially very dangerous chemicals that we're then going to recommend to the entire population.
It's a it's pretty it's not a good idea.
during COVID, more or less.
I was at the NIH with the director, Jay Bhattacharyya.
I was a senior science strategist and helping him to get various types of policies to help improve scientific research in our country.
Showing 361–380 of 522 · page 19 of 27
← Previous
Next →